Literature DB >> 1021513

Examination of antitumor activities of platinum complexes of 1,2-diaminocyclohexane isomers and their related complexes.

Y Kidani, K Inagaki, S Tsukagoshi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1021513

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


× No keyword cloud information.
  11 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

Review 2.  Oxaliplatin: pharmacokinetics and chronopharmacological aspects.

Authors:  F Lévi; G Metzger; C Massari; G Milano
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

3.  Phase I study of oxaliplatin in patients with advanced cancer.

Authors:  J M Extra; M Espie; F Calvo; C Ferme; L Mignot; M Marty
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits.

Authors:  R Kizu; S Higashi; Y Kidani; M Miyazaki
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.

Authors:  Yoshitaka Honma; Yasuhide Yamada; Tetsuji Terazawa; Atsuo Takashima; Satoru Iwasa; Ken Kato; Tetsuya Hamaguchi; Yasuhiro Shimada; Masaki Ohashi; Shinji Morita; Takeo Fukagawa; Nozomu Machida; Hitoshi Katai
Journal:  Surg Today       Date:  2015-11-13       Impact factor: 2.549

6.  Dichloro(1,2-Diaminocyclohexane)Platinum(II) (DACHPt) Loaded Polymer Micelles with Cross-Linked Core: Preparation and Characterization.

Authors:  Hardeep S Oberoi; Nataliya V Nukolova; Tatiana K Bronich
Journal:  PMSE Preprints       Date:  2011

7.  Oxaliplatin and its enantiomer induce different condensation dynamics of single DNA molecules.

Authors:  Hong-Yan Zhang; Yu-Ru Liu; Chao Ji; Wei Li; Shuo-Xing Dou; Ping Xie; Wei-Chi Wang; Ling-Yun Zhang; Peng-Ye Wang
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 8.  Chiral discrimination in platinum anticancer drugs.

Authors:  Michele Benedetti; Jaroslav Malina; Jana Kasparkova; Viktor Brabec; Giovanni Natile
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

9.  Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

Authors:  D Roberts; J Schick; S Conway; S Biade; P B Laub; J P Stevenson; T C Hamilton; P J O'Dwyer; S W Johnson
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

10.  Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer clinical T4 or N2-3.

Authors:  Akiko Serizawa; Hidekazu Kuramochi; Kiyoaki Taniguchi; Masaho Ota; Satoshi Katagiri; Takuji Yamada; Sho Kotake; Shunichi Ito; Kazuomi Suzuki; Masakazu Yamamoto
Journal:  Med Oncol       Date:  2021-07-24       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.